
Dr. Albert Bourla
Dr. Albert Bourla is the Chairman and CEO of Pfizer, a multinational pharmaceutical corporation known for developing vaccines and medicines. He has been at the forefront of the global COVID-19 pandemic response, leading Pfizer in the development of one of the first vaccines against the virus. His leadership during this critical time has garnered significant media attention, particularly regarding the company's partnerships and the ethical considerations surrounding vaccine distribution and healthcare policies.
Born on Oct 21, 1961 (63 years old)
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
United States | 10 | 5.00 | 0.32% | +0% | 331,002,651 | 1,048,472 | $21,000,000 | 66,519$ |
Totals | 10 | 331,002,651 | 1,048,472 | $21,000,000 | 66,519$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5
United States:
'We agree to disagree': Pfizer CEO on working with HHS despite vaccine views.
5